Letter

Reply to letters on ethics of trials from bayesian perspective

BMJ 2003; 327 doi: 10.1136/bmj.327.7406.105 (Published 10 July 2003)
Cite this as: BMJ 2003;327:105.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Richard J Lilford, professor of clinical epidemiology (r.j.lilford@bham.ac.uk)
  1. Department of Public Health and Epidemiology, Public Health Building, University of Birmingham, Birmingham B15 2TT

    EDITOR–In response to my paper Kunkler disagrees that telling people emphatically that “the best treatment is unknown” suppresses sophisticated questioning by the patient.1 2 But this was not my opinion: I was merely quoting what Donovan et al reported in their original paper.3 I was therefore pleased that instead of following Donovan et al's injunction to be unequivocal about uncertainty Hamdy et al give those …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular